BIO-key International, Inc.
BKYI
$0.75
$0.011.35%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -0.77% | -18.02% | -10.64% | -5.15% | -3.86% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -0.77% | -18.02% | -10.64% | -5.15% | -3.86% |
| Cost of Revenue | -62.84% | -76.06% | -79.61% | -45.29% | -8.03% |
| Gross Profit | 81.00% | 107.65% | 294.06% | 88.84% | 2.23% |
| SG&A Expenses | -15.17% | -14.02% | -10.50% | -15.62% | -20.30% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -24.13% | -31.51% | -34.02% | -24.50% | -18.00% |
| Operating Income | 47.86% | 45.32% | 54.56% | 40.65% | 28.67% |
| Income Before Tax | 39.23% | 39.15% | 50.05% | 56.57% | 50.19% |
| Income Tax Expenses | 91.70% | 82.84% | 82.84% | -326.14% | -325.94% |
| Earnings from Continuing Operations | 36.95% | 38.36% | 49.53% | 59.12% | 52.69% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 36.95% | 38.36% | 49.53% | 59.12% | 52.69% |
| EBIT | 47.86% | 45.32% | 54.56% | 40.65% | 28.67% |
| EBITDA | 50.42% | 47.50% | 56.97% | 43.69% | 30.36% |
| EPS Basic | 86.62% | 84.22% | 86.38% | 76.52% | 68.28% |
| Normalized Basic EPS | 88.00% | 85.05% | 87.19% | 66.79% | 55.54% |
| EPS Diluted | 86.62% | 84.22% | 86.38% | 76.52% | 68.28% |
| Normalized Diluted EPS | 88.00% | 85.05% | 87.19% | 66.79% | 55.54% |
| Average Basic Shares Outstanding | 252.59% | 244.71% | 283.20% | 175.92% | 124.93% |
| Average Diluted Shares Outstanding | 252.59% | 244.71% | 283.20% | 175.92% | 124.93% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |